Review of sertraline and its clinical applications in psychiatric disorders

Expert Opinion on Pharmacotherapy
A L McRae, K T Brady

Abstract

Sertraline (Zoloft, Pfizer) has been shown in numerous controlled studies to have similar efficacy to other selective serotonin (5-HT) re-uptake inhibitors (SSRIs) in the treatment of depression and anxiety disorders. Further research is indicating that the efficacy of sertraline extends even beyond the treatment of depression and anxiety to include utility in eating disorders, premenstrual dysphoric disorder (PMDD) and possibly substance abuse treatment. Along with other SSRIs, sertraline offers several advantages over older antidepressants, including improved patient tolerability, low risk of lethality in overdose and no dependence potential. In head-to-head comparisons, sertraline appears to be at least as well-tolerated as other SSRIs and may even have a more favourable side effect profile. Low potential for pharmacokinetic drug interactions is another advantage of sertraline. Unlike fluoxetine, fluvoxamine and paroxetine, sertraline is not a potent inhibitor of any of the cytochrome P450 isoenzyme systems. As a result of its proven efficacy, good tolerability and lack of pharmacokinetic interactions, sertraline should be considered first-line in the treatment of anxiety and depressive disorders.

References

Apr 1, 1992·Alcoholism, Clinical and Experimental Research·D A Gorelick, A Paredes
Aug 5, 1992·JAMA : the Journal of the American Medical Association·S D SolomonA M Muff
Jul 1, 1990·The American Journal of Psychiatry·M A JenikeR Seymour
Apr 1, 1990·Clinical Pharmacology and Therapeutics·C A NaranjoE M Sellers
Aug 1, 1995·The American Journal of Drug and Alcohol Abuse·L CoviC A Haertzen
Sep 1, 1995·The American Journal of Psychiatry·D J KatzelnickR C Serlin
Mar 1, 1995·The American Journal of Psychiatry·H R KranzlerN Liebowitz
Aug 1, 1994·Journal of Clinical Psychopharmacology·L L AltshulerD Ames
Jan 1, 1993·International Clinical Psychopharmacology·E AgugliaF Bolino
Jun 1, 1993·Journal of Clinical Psychopharmacology·L D LaPorta
Jun 1, 1996·Drug and Alcohol Dependence·S L BatkiR T Jones
Oct 1, 1995·Journal of Clinical Psychopharmacology·V D CzepowiczJ C Ballenger
Oct 1, 1996·Journal of Traumatic Stress·B O RothbaumL Thomas
Nov 23, 1996·Lancet·C BerghP Södersten
Jan 1, 1994·Anxiety·D J MunjackT V Eagan
Jan 1, 1994·Anxiety·E A MartinsB Dubbert
Jul 1, 1997·The Journal of Clinical Psychiatry·J ZajeckaS Mitchell
Aug 1, 1997·Archives of General Psychiatry·J R CorneliusA Black
Aug 1, 1997·Psychopharmacology·L L von MoltkeR I Shader
Dec 31, 1997·The Journal of Clinical Psychiatry·L K SolaiC F Reynolds
Jan 1, 1997·Depression and Anxiety·D C SteffensM J Helms
Jan 27, 1998·Archives of Family Medicine·R J Goldberg
Jan 1, 1997·European Journal of Clinical Pharmacology·M M StahlJ S Schou
May 8, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J HigleyM Linnoila
Jul 3, 1998·Drug and Alcohol Dependence·I PetrakisB Rounsaville
Apr 30, 1999·Journal of Psychopharmacology·P K Gillman
Jun 24, 1999·Cellular and Molecular Neurobiology·C L DeVane
Oct 3, 1999·Journal of Clinical Psychopharmacology·D J GreenblattR I Shader
Apr 19, 2000·JAMA : the Journal of the American Medical Association·K BradyG M Farfel
Jun 1, 2000·The American Journal of Psychiatry·S L McElroyJ I Hudson
Aug 3, 2000·Alcoholism, Clinical and Experimental Research·H M PettinatiA Cnaan
Apr 1, 1997·Journal of Clinical Psychopharmacology·B A SprouleE M Sellers
Apr 1, 1997·Journal of Clinical Psychopharmacology·N R Pinninti, J de Leon
Apr 1, 1997·Journal of Clinical Psychopharmacology·S Madhusoodanan, R Brenner
Dec 6, 2000·Journal of Clinical Psychopharmacology·A Aberg-WistedtA C Akerblad
Dec 8, 2000·International Clinical Psychopharmacology·J I SheikhR Fayyad
Feb 26, 2008·CNS Spectrums·C K FarrenS O'Malley

❮ Previous
Next ❯

Citations

Mar 22, 2005·Chirality·George J Quallich
Mar 24, 2004·Mutation Research·Gokay BozkurtCetin Algunes
Feb 27, 2014·Chemical Reviews·J Johan VerendelPher G Andersson
Mar 1, 2009·International Clinical Psychopharmacology·David V Sheehan, Kunitoshi Kamijima
Oct 22, 2002·Expert Opinion on Pharmacotherapy·Ann C Schwartz, Barbara O Rothbaum
Nov 5, 2003·Expert Opinion on Pharmacotherapy·Uriel Halbreich, Linda S Kahn
Jul 31, 2007·Expert Opinion on Pharmacotherapy·John ParissisDimitrios T Kremastinos
Sep 8, 2011·Alcoholism, Clinical and Experimental Research·Henry R KranzlerHoward Tennen
Aug 19, 2015·NeuroImage·Bernadet L KlaassensJoop M A van Gerven
Jun 30, 2015·Journal of the American Chemical Society·Bin XuQi-Lin Zhou
Dec 9, 2014·Journal of the American Chemical Society·Zhaobin WangJianwei Sun
Jun 28, 2016·Journal of the American Chemical Society·Stig D FriisStephen L Buchwald
Jun 8, 2017·Organic Letters·Zining WangQian Zhang
Feb 3, 2018·Angewandte Chemie·Yu-Feng LiuBing-Tao Guan
Aug 16, 2003·Journal of Clinical Psychopharmacology·Kirsten BehnkeEstelle D Vester-Blokland
Jun 22, 2016·Chemical Record : an Official Publication of the Chemical Society of Japan ... [et Al.]·Oscar Pàmies, Montserrat Diéguez
Aug 15, 2013·Dalton Transactions : an International Journal of Inorganic Chemistry·Alban Cadu, Pher G Andersson
Aug 9, 2019·Nature Communications·Xiaokai ChengZhan Lu
Jul 4, 2002·Journal of the American Chemical Society·Nick A Paras, David W C MacMillan
Apr 14, 2017·Journal of the American Chemical Society·Kelsey E PorembaSarah E Reisman
Feb 28, 2018·The Journal of Organic Chemistry·Takahiro Sawano, Hisashi Yamamoto
Sep 8, 2017·Journal of the American Chemical Society·Fenglin ChenShaolin Zhu
Nov 5, 2020·Journal of the American Chemical Society·Sheng-Peng JiangXin-Yuan Liu
Sep 21, 2021·Journal of the American Chemical Society·Sii Hong LauAbigail G Doyle
Aug 4, 2005·Journal of the American Chemical Society·Jean-François PaquinErick M Carreira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Opinion on Pharmacotherapy
Ann C Schwartz, Barbara O Rothbaum
Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Annerose BarrosDomingos O d'Avila
© 2021 Meta ULC. All rights reserved